Schroder Investment Management Group’s Medline Inc MDLN Stock Holding History

Schroder Investment Management Group’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+5,160	New	+$208K	﹤0.01%	1147

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Schroder Investment Management Group's MDLN Position: Q2 2026 in Review

Schroder Investment Management Group opened a new position in Medline Inc (MDLN) in Q2 2026: 5,160 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1147 among its holdings.

405 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Schroder Investment Management Group held 5,160 shares of Medline Inc worth $204K as of Q2 2026.
Medline Inc was a new Schroder Investment Management Group position in Q2 2026.
Medline Inc made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #1147 holding.
405 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.